C. Dye, S. Scheele, P. Dolin, V. Pathania, and M. Raviglione, Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project, JAMA J Am Med Assoc Aug, vol.18282, issue.7, pp.677-86, 1999.

O. Mondiale-de and L. Santé, Rapport 2013 sur la lutte contre la tuberculose dans le monde [Internet] Available from

D. Antoine, F. Belghiti, J. Guthmann, C. Campese, D. Lévy-bruhl et al., Les cas de tuberculose déclarés en France en 2012, Bull Epidémiol Hebd. Juin, issue.20, pp.352-361, 2014.

D. Antoine and C. D. , Épidémiologie de la tuberculose en France: bilan des cas déclarés en, Bull Epidémiol Hebd, pp.27-35, 2008.

D. Antoine and C. D. , Les cas de tuberculose déclarés en France en 2010. Bull Epidémiologique Hebd InVS, Juin, pp.24-25285, 2012.

K. Cain, S. Benoit, C. Winston, M. Kenzie, and W. , Tuberculosis among Foreign-born Persons in the United States, American Journal of Respiratory and Critical Care Medicine, vol.175, issue.1, pp.405-417, 2008.
DOI : 10.1164/rccm.200608-1178OC

H. Mallet, D. Abiteboul, F. Blanc-jouvan, A. Carbonne, C. D. et al., Recomm Prat Groupe Trav Cons Supér D'Hygiène Publique Fr, p.85, 2006.

P. Fraisse, Diagnostic des infections tuberculeuses latentes (sujets sains, sujets immunod??prim??s ou amen??s ?? l?????tre), Revue des Maladies Respiratoires, vol.29, issue.2, pp.277-318, 2012.
DOI : 10.1016/j.rmr.2011.05.019

P. Fraisse, Traitement des infections tuberculeuses latentes, Revue des Maladies Respiratoires, vol.29, issue.4, pp.579-600, 2012.
DOI : 10.1016/j.rmr.2011.07.011

D. Abiteboul, D. Antoine, F. Antoun, P. Tattevin, P. Fraisse et al., Enquête autour d'un cas de tuberculose (2013) Recomm Prat Groupe Travil Haut Cons Santé Publique, 2013.

T. Comolet, Rapport d'activité et de performance concernant la tuberculose Journée nationale d'information et d'échanges sur la tuberculose.; 2013 Avril

E. Langenskiold, F. Herrmann, B. Luong, T. Rochat, and J. Janssens, Contact tracing for tuberculosis and treatment for latent infection in a low incidence country, Swiss Med Wkly. Feb, vol.9138, pp.5-678, 2008.

C. Horsburgh, S. Goldberg, J. Bethel, S. Chen, P. Colson et al., Latent TB Infection Treatment Acceptance and Completion in the United States and Canada, Chest, vol.137, issue.2, 2010.
DOI : 10.1378/chest.09-0394

P. Rivest, M. Street, and R. Allard, Completion rates of treatment for latent tuberculosis infection in Quebec, Can J Public Health Rev Can Santé Publique, 2006.

M. Reichler, R. Reves, S. Bur, V. Thompson, B. Mangura et al., Evaluation of Investigations Conducted to Detect and Prevent Transmission of Tuberculosis, JAMA, vol.287, issue.8, pp.991-996, 2002.
DOI : 10.1001/jama.287.8.991

C. Driver, M. Balcewicz-sablinska, Z. Kim, J. Scholten, and S. Munsiff, Contact investigations in congregate settings, Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis, 2003.

J. Jereb, S. Etkind, O. Joglar, M. Moore, and Z. Taylor, Tuberculosis contact investigations: outcomes in selected areas of the United States, Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis, vol.7, issue.12, pp.384-90, 1999.

M. Reichler, R. Reves, S. Bur, J. Ford, V. Thompson et al., Treatment of Latent Tuberculosis Infection in Contacts of New Tuberculosis Cases in the United States, Southern Medical Journal, vol.95, issue.4, pp.414-434, 2002.
DOI : 10.1097/00007611-200295040-00009

H. Anger, D. Proops, T. Harris, J. Li, B. Kreiswirth et al., Active Case Finding and Prevention of Tuberculosis Among a Cohort of Contacts Exposed to Infectious Tuberculosis Cases in New York City, Clinical Infectious Diseases, vol.54, issue.9, pp.1287-95, 2012.
DOI : 10.1093/cid/cis029

B. Smith, K. Schwartzman, G. Bartlett, and D. Menzies, Adverse events associated with treatment of latent tuberculosis in the general population, Canadian Medical Association Journal, vol.183, issue.3, pp.173-182, 2011.
DOI : 10.1503/cmaj.091824

S. Lee, Y. Liu, T. Huang, Y. Chen, H. Tsai et al., Comparison of the interferongamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers, Scand J Infect Dis, vol.40, issue.5, pp.373-80, 2008.

J. Nania, J. Skinner, K. Wilkerson, J. Warkentin, V. Thayer et al., Conclusion., Infection Control & Hospital Epidemiology, vol.54, issue.06, pp.661-666, 2007.
DOI : 10.1001/jama.287.8.991

H. Kazama, H. Nigorikawa, M. Kashiwa, S. Miyokawa, M. Tanaka et al., Contact investigation using QuantiFERON-TB Gold test to evaluate TB exposure in 61 subjects in a hospital setting--(2) Change in QuantiFERON response during one year after exposure], Kekkaku. 2013, vol.88, issue.4, pp.411-417

F. Ringshausen, S. Schlösser, A. Nienhaus, A. Schablon, G. Schultze-werninghaus et al., In-hospital contact investigation among health care workers after exposure to smear-negative tuberculosis, Journal of Occupational Medicine and Toxicology, vol.4, issue.1, p.11, 2009.
DOI : 10.1186/1745-6673-4-11

M. Gulati, D. Liss, J. Sparer, M. Slade, E. Holt et al., Risk Factors for Tuberculin Skin Test Positivity in an Industrial Workforce Results of a Contact Investigation, Journal of Occupational and Environmental Medicine, vol.47, issue.11, pp.1190-1199, 2005.
DOI : 10.1097/01.jom.0000183098.29627.47

M. Bagherirad, P. Trevan, M. Globan, E. Tay, N. Stephens et al., Transmission of tuberculosis infection in a commercial office, The Medical Journal of Australia, vol.200, issue.3, pp.177-186, 2014.
DOI : 10.5694/mja12.11750

A. Davidow, B. Mangura, M. Wolman, S. Bur, R. Reves et al., Workplace contact investigations in the United States, Int J Tuberc Lung Dis, vol.7, issue.12, pp.446-52, 2003.

H. Ohno, Y. Ikegami, K. Kishida, Y. Yamamoto, N. Ikeda et al., A contact investigation of the transmission of Mycobacterium tuberculosis from a nurse working in a newborn nursery and maternity ward, Journal of Infection and Chemotherapy, vol.14, issue.1, pp.66-71, 2008.
DOI : 10.1007/s10156-007-0565-0

H. Conseil-de-la-santé-publique, Surveiller et prévenir les infections associées aux soins. Hygiènes, p.175, 2010.

. Invs, Comment signaler et notifier la tuberculose ? / Tuberculose / Maladies à déclaration obligatoire / Maladies infectieuses / Dossiers thématiques, Accueil, p.2011, 2014.

C. Supérieur-d-'hygiène-publique-de-france, Avis relatif à la déclaration obligatoire des issues de traitement dans la tuberculose maladie, Ministère de la Santé et des Solidarités, 2006.

M. Dara, K. Kremer, M. Van-der-werf, C. Ködmön, and P. Zucs, Tuberculosis surveillance and monitoring in Europe 2013. World Health Organization & European Centre for Disease Prevention and Control, p.228

D. Lévy-bruhl, H. Mallet, C. Strady, and S. Larnaudie, Comparison of various tuberculosis screening strategies based on tuberculin testing in schoolchildren in Paris]. Rev Dépidémiologie Santé Publique, pp.253-262, 2008.

F. Rey and C. , Estimation du risque annuel d???infection tuberculeuse dans les Bouches-du-Rh??ne chez les enfants vaccin??s par le BCG, Revue des Maladies Respiratoires, vol.23, pp.41-41, 2006.
DOI : 10.1016/S0761-8425(06)72183-0

D. Abiteboul, D. Antoine, F. Antoun, and C. D. , Tuberculose et tests de détection de l'interféron gamma. Recomm Prat Groupe Trav Cons Supér D'Hygiène Publique Fr, Juillet, vol.46, 2011.

D. Circulaire and . Sd5c, relative à la pratique de la vaccination par le vaccin antituberculeux BCG, 2004.

D. Keyser, E. , D. Keyser, F. , D. Baets et al., Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection, Acta Clinica Belgica, vol.14, issue.10, 2014.
DOI : 10.1136/ard.62.9.829

R. Diel, R. Loddenkemper, K. Meywald-walter, R. Gottschalk, and A. Nienhaus, Comparative Performance of Tuberculin Skin Test, QuantiFERON-TB-Gold In Tube Assay, and T-Spot.TB Test in Contact Investigations for Tuberculosis, Chest, vol.135, issue.4, pp.1010-1018, 2009.
DOI : 10.1378/chest.08-2048

P. Andersen, M. Munk, J. Pollock, and T. Doherty, Specific immune-based diagnosis of tuberculosis. The Lancet, pp.1099-104, 2000.

Y. Kang, H. Lee, and H. Yoon, Discrepancy Between the Tuberculin Skin Test and the Whole-Blood Interferon ?? Assay for the Diagnosis of Latent Tuberculosis Infection in an Intermediate Tuberculosis-Burden Country, JAMA, vol.293, issue.22, pp.2756-61, 2005.
DOI : 10.1001/jama.293.22.2756

D. Rose, C. Schechter, and J. Adler, Interpretation of the tuberculin skin test, Journal of General Internal Medicine, vol.267, issue.suppl 2, pp.635-677, 1995.
DOI : 10.1007/BF02602749

G. Mazurek, J. Jereb, A. Vernon, P. Lobue, S. Goldberg et al., Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection, United States, Department of Health and Human Services, 2010.

T. Yoshiyama, N. Harada, K. Higuchi, Y. Sekiya, and K. Uchimura, Use of the QuantiFERON®-TB Gold test for screening tuberculosis contacts and predicting active disease, Int J Tuberc Lung Dis, vol.14, issue.7, pp.819-846, 2010.

C. Erkens, M. Kamphorst, I. Abubakar, G. Bothamley, D. Chemtob et al., Tuberculosis contact investigation in low prevalence countries: a European consensus, European Respiratory Journal, vol.36, issue.4, pp.925-974, 2010.
DOI : 10.1183/09031936.00201609

R. Pitman, B. Jarman, and R. Coker, Tuberculosis transmission and the impact of intervention on the incidence of infection, Int J Tuberc Lung Dis, vol.6, issue.6, pp.485-91, 2002.

A. Hill, J. Becerra, and K. Castro, Modelling tuberculosis trends in the USA, Epidemiology and Infection, vol.72, issue.10, pp.1862-72, 2012.
DOI : 10.1164/rccm.200701-057OC

F. Naudin, V. Briend-godet, J. Chevallier, C. Biron, L. Cellerin et al., Traitement des infections tuberculeuses latentes (ITL) au Centre de Lutte Anti Tuberculeuse du CHU de Nantes : évaluation de l'observance et de la tolérance, Available from, 2008.

Y. Hirsch-moverman, A. Daftary, J. Franks, and P. Colson, Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada [Review article], Int J Tuberc Lung Dis, vol.12, issue.11, pp.1235-54, 2008.

T. Rennie, G. Bothamley, D. Engova, and I. Bates, Patient choice promotes adherence in preventive treatment for latent tuberculosis, European Respiratory Journal, vol.30, issue.4, pp.728-763, 2007.
DOI : 10.1183/09031936.00034007

L. Dash, G. Comstock, and J. Flynn, Isoniazid preventive therapy: Retrospect and prospect, Am Rev Respir Dis, vol.121, issue.6, pp.1039-1083, 1980.

A. Lardizabal, M. Passannante, F. Kojakali, C. Hayden, and L. Reichman, Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin*. Chest, pp.1712-1719, 2006.

D. Générale-de and L. Santé, Comité Technique de Vaccination. Guide des vaccinations édition 2012, Principes et bases immunologiques de la vaccination. INPES, 2012.

C. Bonah and P. Menut, La longue marche d'un vétéran. Dossier BCG. La Recherche, pp.70-73, 2002.

C. N° and D. , 318 du 14 août 2007 relative à la suspension de l'obligation de vaccination par le BCG des enfants et des adolescents, 2007.

A. Hesseling, M. Cotton, C. Von-reyn, S. Graham, R. Gie et al., Prise de position de consensus au sujet des recommandations révisées de l'Organisation Mondiale de la Santé sur la vaccination par le BCG des nouveau-nés infectés par le VIH, Int J Tuberc Lung Dis, vol.12, issue.12, pp.1376-1385, 2008.

B. Trunz, P. Fine, and C. Dye, Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness, The Lancet, vol.367, issue.9517, pp.1173-80, 2006.
DOI : 10.1016/S0140-6736(06)68507-3

L. Rodrigues, V. Diwan, and J. Wheeler, Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-Analysis, International Journal of Epidemiology, vol.22, issue.6, pp.1154-1162, 1993.
DOI : 10.1093/ije/22.6.1154

H. Rieder, Interventions for Tuberculosis Control and Elimination, International Union Against Tuberculosis and Lung Disease, 2002.

G. Colditz, T. Brewer, and C. Berkey, Efficacy of BCG Vaccine in the Prevention of Tuberculosis, JAMA, vol.271, issue.9, pp.698-702, 1994.
DOI : 10.1001/jama.1994.03510330076038

H. Mcshane, A. Pathan, C. Sander, S. Keating, S. Gilbert et al., Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans, Nature Medicine, vol.169, issue.11, pp.1240-1244, 2004.
DOI : 10.1016/0882-4010(87)90077-5

L. Rodrigues, S. Pereira, S. Cunha, B. Genser, M. Ichihara et al., Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial, The Lancet, vol.366, issue.9493, pp.1290-1295, 2005.
DOI : 10.1016/S0140-6736(05)67145-0

P. Hart and I. Sutherland, BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life., BMJ, vol.2, issue.6082, pp.293-298, 1977.
DOI : 10.1136/bmj.2.6082.293

N. Guérin and . La-vaccination-par-le-bcg-en-france, Historique et évolution jusqu'à la suspension de l'obligation vaccinale

A. Lotte, O. Wasz-hockert, N. Poisson, H. Engbaek, H. Landmann et al., Second IUATLD study on complications induced by intradermal BCG-vaccination, Bull Int Union Tuberc Lung Dis, vol.63, issue.2, pp.47-59, 1988.

. De-la-lutte-antituberculeuse-en-france, Le site santé du Ministère des Affaires Sociales et de la Santé Available from: http://www.sante.gouv.fr/l-organisation-de-la-lutte-antituberculeuse-en-france.html 92. Comité national d'élaboration du programme de lutte contre la tuberculose, 2007.

D. Circulaire-interministérielle and . Dgcl, relative à la mise en oeuvre de la recentralisation des activités de dépistage du cancer, de vaccination, de lutte contre la tuberculose, la lèpre et les infections sexuellement transmissibles et aux orientations pour la négociation des conventions permettant l, 2005.

R. Sloot, M. Schim-van-der-loeff, P. Kouw, and M. Borgdorff, Yield of tuberculosis contact investigations in Amsterdam: opportunities for improvement, European Respiratory Journal, vol.44, issue.3, 2014.
DOI : 10.1183/09031936.00009114

C. Mulder, H. Van-deutekom, E. Huisman, W. Meijer-veldman, C. Erkens et al., Coverage and yield of tuberculosis contact investigations in the Netherlands, The International Journal of Tuberculosis and Lung Disease, vol.15, issue.12, pp.1630-1637, 2011.
DOI : 10.5588/ijtld.11.0027

K. Aissa, F. Madhi, N. Ronsin, F. Delarocque, A. Lecuyer et al., Evaluation of a Model for Efficient Screening of Tuberculosis Contact Subjects, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.9, pp.1041-1048, 2008.
DOI : 10.1164/rccm.200711-1756OC

G. Fox, S. Barry, W. Britton, and G. Marks, Contact investigation for tuberculosis: a systematic review and meta-analysis, European Respiratory Journal, vol.41, issue.1, pp.140-56, 2013.
DOI : 10.1183/09031936.00070812

. Loi, relative à l'organisation de la médecine du travail, 2011.

P. Tattevin, G. Carcelain, A. Fournier, and F. Antoun, Tuberculose et santé au travail. Gd Angle TC 142 Réf Santé Trav, Décembre, issue.132, pp.15-31, 2012.

D. Menzies, R. Joshi, and M. Pai, Risk of tuberculosis infection and disease associated with work in health care settings, Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis, vol.11, issue.6, pp.593-605, 2007.

A. Seidler, A. Nienhaus, and R. Diel, Review of Epidemiological Studies on the Occupational Risk of Tuberculosis in Low-Incidence Areas, Respiration, vol.72, issue.4, pp.431-477, 2005.
DOI : 10.1159/000086261

C. Supérieur-d-'hygiène-publique-de-france, Avis relatif à la revaccination par le BCG et aux modalités de surveillance des professionnels exposés à la tuberculose, 2002.

P. Fraisse, Pr??vention de la tuberculose dans les lieux de soins, Revue des Maladies Respiratoires, vol.22, issue.3, pp.431-478, 2005.
DOI : 10.1016/S0761-8425(05)85571-8

A. Zwerling, S. Van-den-hof, J. Scholten, F. Cobelens, D. Menzies et al., Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review, Thorax, vol.67, issue.1, 2012.
DOI : 10.1136/thx.2010.143180

M. Joloba, J. Johnson, A. Namale, A. Morrissey, A. Assegghai et al., Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis, Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis, vol.4, issue.6, pp.528-564, 2000.

T. Kim, R. Blackman, K. Heatwole, T. Kim, and D. Rochester, Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment, Am Rev Respir Dis Feb, vol.129, issue.2, pp.264-272, 1984.

M. Behr, S. Warren, H. Salamon, P. Hopewell, A. Ponce-de-leon et al., Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli, The Lancet, vol.353, issue.9151, pp.444-453, 1999.
DOI : 10.1016/S0140-6736(98)03406-0

E. Hernández-garduño, V. Cook, D. Kunimoto, R. Elwood, W. Black et al., Transmission of tuberculosis from smear negative patients: a molecular epidemiology study, Thorax, vol.59, issue.4, 2004.
DOI : 10.1136/thx.2003.011759

O. Castel, B. C. , A. B. , U. M. , and C. F. Patte-f, Analyse d'une épidémie de tuberculose en 1992 dans le service de pneumo-phtisiologie du CHU de Poitiers. FR, 1994.

H. Kantor, R. Poblete, and S. Pusateri, Nosocomial transmission of tuberculosis from unsuspected disease, The American Journal of Medicine, vol.84, issue.5, pp.833-841, 1988.
DOI : 10.1016/0002-9343(88)90060-5